Clinical Trials Logo

Sleep Wake Disorders clinical trials

View clinical trials related to Sleep Wake Disorders.

Filter by:

NCT ID: NCT05396729 Recruiting - Sleep Disorder Clinical Trials

Acupoint Stimulation Improves Sleep on the Plateau

ASSOP
Start date: July 30, 2022
Phase: N/A
Study type: Interventional

Sleep disorder is common in people going to plateau. Acupuncture and related techniques could be used for treatment of sleep disorder. In this trial the effect of transcutaneous electrical acupoint stimulation on sleep disorder in people going to plateau will be investigated.

NCT ID: NCT05382923 Recruiting - Clinical trials for Circadian Rhythm Sleep Disorder, Jet Lag Type

Facilitating Adjustment to Simulated Jet Lag

Start date: July 10, 2021
Phase: N/A
Study type: Interventional

The aims of this study are to compare 3 different treatments for circadian adjustment to a laboratory protocol which will mimic westward air travel across 8 time zones. One treatment will involve simply following the new schedule for 3 days. Another treatment will also involve exposure to bright light for 1 hour per day. A third treatment will involve exposure to bright light + exercise for 1 hour per day + consuming a melatonin tablet. Adjustment to the shifted schedule will be assessed by comparing measures of sleep, mood, mental performance, physical performance, and timing of melatonin across the 3 treatment conditions.

NCT ID: NCT05382754 Recruiting - Clinical trials for Sleep Apnea, Obstructive

Home Apnea Testing in CHildren Trial

HATCH
Start date: March 29, 2023
Phase: N/A
Study type: Interventional

This clinical trial will compare home sleep apnea testing with the gold standard in-lab polysomnography in terms of 1) accuracy, 2) therapeutic decision-making, and 3) parent/child acceptability in children referred for evaluation of obstructive sleep apnea.

NCT ID: NCT05376475 Recruiting - Sleep Clinical Trials

Sleep in Late Pregnancy - Artificial Intelligence Development for the Detection of Disturbances and Disorders

SLeeP AID4
Start date: July 6, 2022
Phase:
Study type: Observational

SLeeP AID4 is a single-group, single-arm, Canada-wide, non-randomised, unblinded, in-home, observational study to prospectively collect and build a data set of natural sleep behaviour and physiology in maternal-fetal dyads (and bed partners, if applicable) in the third trimester of pregnancy in the home setting and subsequently investigate the feasibility of using computer vision technology (CVT) to monitor sleep during and across the third trimester of pregnancy in the home setting for research purposes by eliciting participants' attitudes toward CVT and training, validating, and testing a CVT model to accurately, unobtrusively, non-invasively, and objectively detect and quantify various sleep behaviours, disturbances, and disorders.

NCT ID: NCT05363787 Recruiting - Sleep Disorder Clinical Trials

The Effect of Therapeutic Touch on Sleep Patterns

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to determine the effect of the therapeutic touch applied to the sleep patterns of individuals aged 65-85 years with chronic diseases who are treated in the Neurology Intensive Care Unit of Ankara City Hospital, taking into account the circadian cycle.The type of the research is the experimental model with pre-test and post-test control group.Ankara City Hospital has included the research population in the last year. It will consist of 1593 patients between the ages of 65-85 who are hospitalized in the Neurology Intensive Care Unit.Experimental and control groups will be created with simple randomization in randomization.The data were obtained from the socio-demographic characteristics form and the sleep pattern form developed by the researcher. will be collected with

NCT ID: NCT05361707 Recruiting - Clinical trials for Autism Spectrum Disorder

Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances

Start date: July 28, 2021
Phase: Phase 3
Study type: Interventional

This is a multicenter, open-label study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon in treating sleep disturbances in pediatric and adult participants with ASD.

NCT ID: NCT05359302 Recruiting - Quality of Life Clinical Trials

Effects of Ramadan Fasting on Sleeping and Quality of Life

Start date: March 15, 2022
Phase:
Study type: Observational [Patient Registry]

Include participants who intend to practice Ramadan fasting and accept to complete the three part of the study .

NCT ID: NCT05321355 Recruiting - Insomnia Clinical Trials

Mainz Register of Patients With Sleep Disorders

MAINZ-SLEEPREG
Start date: February 1, 2022
Phase:
Study type: Observational [Patient Registry]

Prospective longitudinal observational registry study of all patients with sleep disorders treated in the Mainz Comprehensive Epilepsy and Sleep Medicine Center with the focus on the course of the disease and quality of life.

NCT ID: NCT05318352 Recruiting - Sleep Disorder Clinical Trials

tDCS in Improving Quality of Sleep in Athletes

tDCS
Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Sleep disturbances in athletes was found prevalent and affect their cognitive and physical abilities and increase the risk of injury. Moreover, studies showed also that a better sleep produces a better athletic performance. Therefore, it is important to find out management strategies that improve quality of sleep in this population. Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation technique that modulates cortical activity. tDCS has been conducted to improve wide range of neurological impairments including sleep. tDCS was used in improving the quality of sleep in older adults and in athletes. Both studies found improvement in some sleep indices.

NCT ID: NCT05247125 Recruiting - Clinical trials for Ischemic Stroke, Acute

The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional)

Start date: March 1, 2022
Phase: Phase 4
Study type: Interventional

There is a lack of complex studies which could establish the association between genetic circadian factors with the features and short-term outcomes of ischemic stroke, as well as the effects of various auxiliary therapies for circadian rhythm modulation for neuroplasticity enhancement and improvement of short-term outcomes in ischemic stroke. The main research hypothesis is that circadian factors influence the recovery from ischemic stroke via sleep-mediated regulation of synaptic plasticity. The project aims at the investigation of the influence of combined melatonin therapy and blue light exposure on molecular circadian biomarkers, sleep characteristics, neuroplasticity markers and stroke outcome in acute stroke patients. This study is a prospective, interventional, randomized placebo-controlled trial.